Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Kymera Therapeutics Inc’s stock clocked out at $49.98, up 0.38% from its previous closing price of $49.79. In other words, the price has increased by $0.38 from its previous closing price. On the day, 0.94 million shares were traded. KYMR stock price reached its highest trading level at $51.2599 during the session, while it also had its lowest trading level at $48.8.
Ratios:
To gain a deeper understanding of KYMR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.45 and its Current Ratio is at 8.45. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.
On August 26, 2024, Wolfe Research Upgraded its rating to Outperform which previously was Peer Perform but kept the price unchanged to $65.
On April 22, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $53.Oppenheimer initiated its Outperform rating on April 22, 2024, with a $53 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 17 ’24 when Esposito Pamela sold 13,500 shares for $48.28 per share. The transaction valued at 651,766 led to the insider holds 0 shares of the business.
PAMELA ESPOSITO bought 13,500 shares of KYMR for $654,480 on Sep 17 ’24. On Aug 26 ’24, another insider, Albers Jeffrey W., who serves as the Director of the company, sold 5,000 shares for $49.10 each. As a result, the insider received 245,508 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYMR now has a Market Capitalization of 3227898368 and an Enterprise Value of 2664655104. For the stock, the TTM Price-to-Sale (P/S) ratio is 35.99 while its Price-to-Book (P/B) ratio in mrq is 4.49. Its current Enterprise Value per Revenue stands at 30.092 whereas that against EBITDA is -15.057.
Stock Price History:
Over the past 52 weeks, KYMR has reached a high of $50.69, while it has fallen to a 52-week low of $9.60. The 50-Day Moving Average of the stock is 10.66%, while the 200-Day Moving Average is calculated to be 36.36%.
Shares Statistics:
It appears that KYMR traded 575.45K shares on average per day over the past three months and 498400 shares per day over the past ten days. A total of 63.76M shares are outstanding, with a floating share count of 57.41M. Insiders hold about 9.95% of the company’s shares, while institutions hold 97.17% stake in the company. Shares short for KYMR as of 1724976000 were 9350577 with a Short Ratio of 16.25, compared to 1722384000 on 9846775. Therefore, it implies a Short% of Shares Outstanding of 9350577 and a Short% of Float of 16.17.
